Hexafluorenium (dibromide)

• UNSPSC Description:

  Hexafluorenium dibromide (Mylaxen) is a potent cholinesterase (ChE) inhibitor with pI50 value of 6.96 and Ki value of 2.4 nM for human plasma cholinesterase (ChE)[1].

• Target Antigen:

  Cholinesterase (ChE)

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/hexafluorenium-dibromide.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C[N+](C)(C1C2=C(C3=C1C=CC=C3)C=CC=C2)CCCCCC[N+](C)(C4C5=C(C6=C4C=CC=C6)C=CC=C5)C.[Br-].[Br-]

• Molecular Weight:

  662.54

• References & Citations:

  [1]Schuh FR. Interaction of hexafluorenium with human plasma cholinesterase in comparison with hexamethonium. Naunyn Schmiedebergs Arch Pharmacol. 1976;293(1):11-3.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Launched

• CAS Number:

  317-52-2